RADY-GU-SAYKIN-TLC; Older breast cancer patients: Risk for cognitive decline
We are looking for healthy women (who have never had cancer) to participate in a study of at Indiana University School of Medicine. We are working to better understand cognitive changes after breast cancer treatment.
The purpose of this study is to evaluate the impact of systemic therapy on cognitive functioning in older breast cancer patients.
- IRB Number: 1602851718
- Research Study Identifier: TX6654
- Principal Investigator: Andrew Saykin, PsyD